[Comparative studies of the therapeutic effect of a herbazol preparation with and without an antacid component in duodenal peptic ulcer patients].
A total of 64 patients were treated - 30 with Herbazol A (with antacid component), 18 with Herbacid B (without antacid component) and 16 - with placebo. Herbazol A was established to eliminate the subjective pain and dyspeptic complaints a little earlier as compared with Herbazol B. Both preparations have the same action as regards the effect on hydrochloric acid gastric secretion and the healing of the ulcer niché.
D000863:Antacids / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D010919:Placebos; D010936:Plant Extracts / Q000627:therapeutic use*; D017693:Sodium Bicarbonate; D013607:Tablets; D013997:Time Factors
D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D010919:Placebos; D010936:Plant Extracts; D013607:Tablets; C041735:herbazol; D017693:Sodium Bicarbonate; D008274:Magnesium; D001729:Bismuth
Sravnitelni prouchvaniia na lechebniia efekt na preparata herbazol sŭs i bez antiatsidna sŭstavka pri bolni s iazvena bolest na duodenuma.